Sanofi has selected the Icertis Contract Management (ICM) platform as its contracting foundation. The ICM platform will help redesign and streamline Sanofi's contracting processes to drive increased business velocity, and improve monitoring and standardization across its contracting operations.
Sanofi chose the Icertis platform to increase adoption and improve contracting speed to provide greater visibility and help manage risk.
"We are thrilled to have Sanofi, a company that is committed to making a real difference in the lives of people every day, as a customer," said Samir Bodas, Co-founder and CEO of Icertis. "As global enterprises like Sanofi look to transform their commercial foundation, treating contracts as valuable assets rather than static documents is a critical component of that transformation. We are excited to partner with Sanofi as they reimagine contract management for the digital era."
The Icertis platform's intelligent risk management capabilities allow companies to identify, assess and automatically mitigate risk, while region-based variations in workflow and support for multiple languages allow companies to monitor regulatory compliance across the globe.
ICM is now used by four of the top seven pharmaceutical companies including Roche, AbbVie, and now Sanofi. In March, the company also introduced an upgrade to their Icertis Clinical Trial Agreement and Budgeting solution designed to improve clinical trials contract management.